Does anti-JCV therapy improve the prognosis of AIDS-related PML?

Mikita, Kei; Maeda, Takuya; Fujikura, Yuji; Kozaki, Yuji; Hara, Yu; Kanoh, Soichiro; Kishida, Shuji; Saijo, Masayuki; Nakamichi, Kazuo; Kawana, Akihiko

Mikita, Kei; Maeda, Takuya; Fujikura, Yuji; Kozaki, Yuji; Hara, Yu; Kanoh, Soichiro; Kishida, Shuji; Saijo, Masayuki; Nakamichi, Kazuo; Kawana, Akihiko.

Affiliation

Mikita K; Department of Infectious Diseases and Pulmonary Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, Japan.

Clin Neurol Neurosurg ; 115(9): 1853-4, 2013 Sep.

Article in En | MEDLINE | ID: mdl-23481900

Subject(s)

HIV Infections/complications; JC Virus; Leukoencephalopathy, Progressive Multifocal/drug therapy; Polyomavirus Infections/drug therapy; Antimalarials/therapeutic use; Brain/pathology; CD4 Lymphocyte Count; Fatal Outcome; HIV-1; Humans; Leukoencephalopathy, Progressive Multifocal/etiology; Male; Mefloquine/therapeutic use; Middle Aged; Polyomavirus Infections/cerebrospinal fluid; Polyomavirus Infections/complications; Prognosis; Viral Load

Key words

JCV; Mefloquine; Progressive multifocal leukoencephalopathy; cART

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Leukoencephalopathy, Progressive Multifocal / JC Virus / Polyomavirus Infections Type of study: Etiology_studies / Prognostic_studies Limits: Humans / Male / Middle aged Language: En Journal: Clin Neurol Neurosurg Year: 2013 Document type: Article Affiliation country: Japan Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google